Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
BioInvent International terminates current BI-505 Phase II study
Monday, December 12, 2016BioInvent International announces that it has decided to terminate its current clinical Phase II study with BI in multiple myeloma The decision follows BioInvents review and discussion with the US Food Drug Administration FDA who put BI on full clin...
FDA has Granted Orphan Drug Designation Request for Biohaven Pharmaceutical's BHV-0223
Saturday, December 10, 2016Biohaven Pharmaceutical Holding Company Ltd announced that the US Food and Drug Administration FDA has granted the Companys orphan drug designation request covering its drug candidate BHV an orally dissolving tablet being developed for the treatment...
AstraZeneca and Lilly enter into agreement to develop MEDI1814 for potential disease-modifying treatment for Alzheimer’s disease (AD)
Saturday, December 10, 2016AstraZeneca and Eli Lilly and Company today announced a worldwide agreement to codevelop MEDI an antibody selective for amyloidbeta A which is currently in Phase I trials as a potential diseasemodifying treatment for Alzheimers disease AD This agree...
Lilly Announces Detailed Results of Solanezumab Phase 3 EXPEDITION3 Study at the Clinical Trials on Alzheimer's Disease (CTAD) 2016 Meeting
Friday, December 09, 2016Eli Lilly and Company NYSE LLY today presented detailed results of its phase EXPEDITION trial at the th Clinical Trials on Alzheimers Disease CTAD meeting As previously disclosed solanezumab did not meet the primary endpoint in the EXPEDITION clinic...
Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in the UK
Friday, December 09, 2016Cardiome Pharma Corp NASDAQ CRME TSX COM announced that it has launched XYDALBA in the UK earlier than expected The European Medicines Agency EMA approved XYDALBA for the treatment of acute bacterial skin and skin structure infections ABSSSI in adul...
Advanced Accelerator Applications Announces CMS Pass-Through Reimbursement Code for its First FDA Approved Drug NETSPOT(R)
Friday, December 09, 2016Advanced Accelerator Applications SA an international specialist in Molecular Nuclear Medicine MNM today announced that the Centers for Medicare Medicaid Services CMS has granted NETSPOT Transitional PassThrough status under an Acode A for drug reim...
Biohaven Announces Orphan Drug Designation Request Granted For BHV-0223 In The Treatment Of Amyotrophic Lateral Sclerosis ("ALS")
Thursday, December 08, 2016Biohaven Pharmaceutical Holding Company Ltd the Company or Biohaven announced today that the US Food and Drug Administration FDA has granted the Companys orphan drug designation request covering its drug candidate BHV an orally dissolving tablet bein...
H2-Pharma Aquires Rights to 15 Mayne Pharma Products
Wednesday, December 07, 2016HPharma LLC announced today that it has acquired the exclusive rights to distribute fifteen products from Mayne Pharma Inc In the combined market for these products was approximately million according to IMS Health HPharma has already launched th...
ENYO Pharma Receives a €2.5 Million Grant from EU under the Horizon2020/SME Instrument Phase 2 Programme for Its Project MIMESIS
Wednesday, December 07, 2016ENYO Pharma a biopharmaceutical company currently focused on developing treatments for viral infections today announced that it has received a grant of million in response to its application to the highly competitive SME Instrument Phase funding pr...
Novartis' Lucentis® received EU approval in new indication - Lucentis the only treatment available for a wide range of CNV conditions
Wednesday, December 07, 2016Novartis today announced that the European Commission EC has granted an additional indication for Lucentis ranibizumab to treat patients with visual impairment due to choroidal neovascularization CNV associated with causes other than neovascular ager...
